Klick Health



Read More

If you’ve read our blog post on the @SanofiUS response to Roseanne Barr’s mention of one of its drugs then you know the basics of the story and the overall conversation volumes. Here, PR Week includes some statements from Sanofi US about the quick turnaround and the necessity of the response.

“Our view is that using our medicines as a crutch for bad behavior is not appropriate,” said [Angela Bechan, head of communications for North America at Sanofi]. “It comes down to our core values at Sanofi: we take diversity and inclusion very seriously. It is part of how we work every day.”

About the speed of turnaround, Bechan said:

“It was not a big leap for anyone to consider that this was the right thing to do because it is consistent with how we work as a company and with the way we feel here.”

Real-time social for pharma companies isn’t easy, and it requires all the regular consultation, but it can be done.


PR Week

More About the Author

Klick Wire

This is the Klick Wire blog account. Here you will find archived versions of all your favorite Klick Wire stories. To get these stories delivered to your inbox every week, use the sign up form at the bottom of this page.

More from this author

Go from news to action. Klick Wire

Weekly Digital Health Newsletter

Klick Health will NEVER spam you. Read our privacy policy

Thank you! You're now signed up to get the Klick Wire every week - news from the world of digital health marketing.

Sorry there seems to be a problem. Please try again later.